Patents Assigned to Ronald T. Stanko
  • Inhibiting growth and spread of malignancy and retarding DNA breaks
    Patent number: 5744498
    Abstract: Growth of an adenocarcinoma in the liver, lung, lymph node or mammary tissue in a mammal can be inhibited by orally administering a therapeutically effective dosage of pyruvate in the form of sodium pyruvate, calcium pyruvate or organic esters of pyruvate. The pyruvate treatment also retards the development of breaks in the DNA strands associated with the malignancy.
    Type: Grant
    Filed: September 16, 1996
    Date of Patent: April 28, 1998
    Assignee: Ronald T. Stanko
    Inventor: Ronald T. Stanko
  • Inhibiting growth of mammary adenocarcinoma
    Patent number: 5612374
    Abstract: Growth of mammary adenocarcinoma in a mammal can be inhibited by orally administering a therapeutically effective dosage of pyruvate in the form of sodium pyruvate, calcium pyruvate or organic esters of pyruvate or precursors of pyruvate.
    Type: Grant
    Filed: February 14, 1994
    Date of Patent: March 18, 1997
    Assignee: Ronald T. Stanko
    Inventor: Ronald T. Stanko